Association between unconjugated bilirubin and schizophrenia

Psychiatry Research

Volumn 189, Issue 3, 2011, Pages 480-482

  Radhakrishnan, Rajiv ^a   Kanigere, Milanduth ^b   Menon, Jayakumar ^b   Calvin, Sam ^b   Janish, Annuncia ^b   Srinivasan, Krishnamachari ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

Author keywords

Biomarker; Schizophrenia; Unconjugated bilirubin

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BILIRUBIN GLUCURONIDE; CHLORPROMAZINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HYPERBILIRUBINEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHIZOPHRENIA; SEX DIFFERENCE;

ADULT; ANALYSIS OF VARIANCE; ASPARTIC ACID; BILIRUBIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERBILIRUBINEMIA; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; YOUNG ADULT;

EID: 80053457307     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2011.03.003     Document Type: Article

References (16)

1. Bach D.R., Kindler J., Strik W.K. Elevated bilirubin in acute and transient psychotic disorder. Pharmacopsychiatry 2010, 43:12-16.
2. Carpenter W.T., Bustillo J.R., Thaker G.K., van Os J., Krueger R.F., Green M.J. The psychoses: cluster 3 of the proposed meta-structure for DSM-V and ICD-11. Psychological Medicine 2009, 39:2025-2042.
3. Dincsoy H.P., Saelinger D.A. Haloperidol-induced chronic cholestatic liver disease. Gastroenterology 1982, 83:694-700.
4. Falcão A.S., Silva R.F., Pancadas S., Fernandes A., Brito M.A., Brites D. Apoptosis and impairment of neurite network by short exposure of immature rat cortical neurons to unconjugated bilirubin increase with cell differentiation and are additionally enhanced by an inflammatory stimulus. Journal of Neuroscience Research 2007, 85:1229-1239.
5. Glen A.I., Glen E.M., Horrobin D.F., Vaddadi K.S., Spellman M., Morse-Fisher N., Ellis K., Skinner F.S. A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases. Schizophrenia Research 1994, 12:53-61.
6. Hayashida M., Miyaoka T., Tsuchie K., Yasuda H., Wake R., Nishida A., Inagaki T., Toga T., Nagami H., Oda T., Horiguchi J. Hyperbilirubinemia-related behavioral and neuropathological changes in rats: a possible schizophrenia animal model. Progress in Neuropsychopharmacology & Biological Psychiatry 2009, 33:581-588.
7. McDonagh A.F. Controversies in bilirubin biochemistry and their clinical relevance. Seminars in Fetal & Neonatal Medicine 2010, 15:141-147.
8. Miyaoka T., Seno H., Itoga M., Horiguchi J. Schizophrenia-associated idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). Journal of Clinical Psychiatry 2000, 61:868-871.
9. Miyaoka T., Yasukawa R., Yasuda H., Shimizu M., Mizuno S., Sukegawa T., Inagaki T., Horiguchi J. Urinary excretion of biopyrrins, oxidative metabolites of bilirubin, increases in patients with psychiatric disorders. European Neuropsychopharmacology 2005, 15:249-252.
10. Müller N., Schiller P., Ackenheil M. Coincidence of schizophrenia and hyperbilirubinemia. Pharmacopsychiatry 1991, 24:225-228.
11. Pae C.U., Paik I.H., Lee C., Lee S.J., Kim J.J., Lee C.U. Decreased plasma antioxidants in schizophrenia. Neuropsychobiology 2004, 50:54-56.
12. Uutela P., Karhu L., Piepponen P., Käenmäki M., Ketola R.A., Kostiainen R. Discovery of dopamine glucuronide in rat and mouse brain microdialysis samples using liquid chromatography tandem mass spectrometry. Analytical Chemistry 2009, 81:427-434.
13. Vítek L., Novotná M., Lenícek M., Novotnỳ L., Eberová J., Petrásek J., Jirsa M. Serum bilirubin levels and UGT1A1 promoter variations in patients with schizophrenia. Psychiatry Research 2010, 178:449-450.
14. Yao J.K., Reddy R., McElhinny L.G., van Kammen D.P. Reduced status of plasma total antioxidant capacity in schizophrenia. Schizophrenia Research 1998, 32:1-8.
15. Yao J.K., Reddy R., van Kammen D.P. Abnormal age-related changes of plasma antioxidant proteins in schizophrenia. Psychiatry Research 2000, 97:137-151.
16. Yasukawa R., Miyaoka T., Yasuda H., Hayashida M., Inagaki T., Horiguch J. Increased urinary excretion of biopyrrins, oxidative metabolites of bilirubin, in patients with schizophrenia. Psychiatry Research 2007, 153:203-207.